Bora Pharmaceuticals Acquires MacroGenics' Manufacturing Operations for $122.5 Million

Intelligence Brief:Bora Pharmaceuticals Acquires MacroGenics' Manufacturing Operations for $122.5 MillionStryker Acquires Amplitude Vascular Systems for Up to $835 MillionBoosting Peripheral Artery Disease PortfolioBristol Myers Squibb and Hengrui Pharma Forge $15.2 Billion OncologyHematologyand Immunology CollaborationCMS Implements Nationwide Six-Month Enrollment Moratoria for Hospice and Home Health Agencies to Combat FraudMobile-health Network Solutions to Receive Up to $100 Million in Private Equity Funding for AI-Powered Healthcare Expansion**(Intro Music fades into a rapid, urgent beat)** **Alex:** Welcome back to Healthcare Daily Pulse, your deep dive into the sector's most impactful movements. I'm Alex, and we're cutting through the market noise to dissect the P&L implications. **Sam:** And I'm Sam, charting the strategic vectors and competitive shifts driving innovation. We've got a dense 15 minutes, so let's jump straight in. First up, a significant play in biologics manufacturing. --- **[NEWS SEGMENT 1: Bora Pharmaceutica...